{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458269166
| IUPAC_name =  
<!-- Clinical data -->
| tradename =  
| pregnancy_category =  
| legal_status = investigational
| routes_of_administration = [[subcutaneous injection]]
<!-- Pharmacokinetic data -->
| bioavailability = N/A
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 330988-75-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q5I7SFZ853
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05393
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| C=502 | H=758 | N=154 | O=165 | S=16
| molecular_weight = 12,103 g/mol (protein part)
}}
'''Pegsunercept''' is a [[pharmaceutical drug|drug]] for the treatment of [[rheumatoid arthritis]]. {{As of|2010|1}}, Phase II [[clinical trial]]s have been completed.<ref>{{ClinicalTrialsGov|NCT00037700|Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis}}</ref><ref>{{ClinicalTrialsGov|NCT00111423|Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)}}</ref><ref name="Furst">{{Cite journal 
| last6 = Solinger 
| pmid = 16331754 
| last5 = Edwards C 
| journal = The Journal of rheumatology 
| last7 = Macri 
| issue = 12 
| last8 = 990136 Study 
| pages = 2303â€“2310 
| volume = 32 
| last4 = Schiff 
| last2 = Fleischmann 
| title = A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis 
| last3 = Kopp 
| last1 = Furst 
| year = 2005 | first1 = D. | first2 = R. | first3 = E. | first4 = M. | first5 = 3. | first6 = A. | first7 = M. | first8 = G.
}}</ref> It is being developed by [[Amgen]].

Similarly to [[etanercept]], pegsunercept is a soluble [[CD120|tumor necrosis factor receptor]]. Pegsunercept is a [[PEGylated]] protein.<ref name="Furst" />

==References==
{{Reflist}}


{{Immunosuppressants}}
{{Cytokine receptor modulators}}

[[Category:TNF inhibitors]]
[[Category:Immunosuppressants]]


{{antineoplastic-drug-stub}}